NCT02154867View on ClinicalTrials.gov

Fecal Microbial Transplantation in Treatment of Irritable Bowel Syndrome; a Double Blinded Placebo Controlled Trial.

PHASE2CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

October 31, 2016

Study Completion Date

December 31, 2016

Conditions
Irritable Bowel Syndrome
Interventions
BIOLOGICAL

Fecal transplantation

Preparation of flesh feces by blending in 0.9 % saline and crude filtering. The solution is applied in proximal colon of IBS patient by colonoscopy after standard bowel preparation.

OTHER

Placebo fecal transplant

Fecal transplantation with own feces

Trial Locations (1)

9406

University Hospital of North Norway, Harstad

All Listed Sponsors
lead

University Hospital of North Norway

OTHER

NCT02154867 - Fecal Microbial Transplantation in Treatment of Irritable Bowel Syndrome; a Double Blinded Placebo Controlled Trial. | Biotech Hunter | Biotech Hunter